Publicacions en què col·labora amb JUAN SAINZ PÉREZ (19)

2023

  1. Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

    International Journal of Molecular Sciences, Vol. 24, Núm. 9, pp. 8005

  2. GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis

    International Journal of Molecular Sciences, Vol. 24, Núm. 7

  3. Identification of novel genetic loci for risk of multiple myeloma by functional annotation

    Leukemia

  4. Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

2022

  1. Autophagy in Hematological Malignancies

    Cancers, Vol. 14, Núm. 20

  2. Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis

    Cancers, Vol. 14, Núm. 10

  3. Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

    Blood Cancer Journal

2021

  1. Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?

    International Journal of Cancer, Vol. 148, Núm. 7, pp. 1616-1624

  2. Functional genetic variants in atg10 are associated with acute myeloid leukemia

    Cancers, Vol. 13, Núm. 6, pp. 1-16

  3. Polymorphisms within autophagy‐related genes influence the risk of developing colorectal cancer: A meta‐analysis of four large cohorts

    Cancers, Vol. 13, Núm. 6, pp. 1-15

  4. Polymorphisms within the TNFSF4 and mapkapk2 loci influence the risk of developing invasive aspergillosis: A two-stage case control study in the context of the aspbiomics consortium

    Journal of Fungi, Vol. 7, Núm. 1, pp. 1-17

  5. Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts

    Frontiers in Immunology, Vol. 12

2020

  1. Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms

    Blood Cancer Journal, Vol. 10, Núm. 8

  2. Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium

    Blood Cancer Journal, Vol. 10, Núm. 7

  3. Polymorphisms within the ARNT2 and CX3CR1 genes are associated with the risk of developing invasive aspergillosis

    Infection and Immunity, Vol. 88, Núm. 4

2019

  1. Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)

    Pharmacogenomics Journal

  2. Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

    Pharmacogenomics Journal, Vol. 19, Núm. 1, pp. 83-96

  3. Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium

    Scientific Reports, Vol. 9, Núm. 1

2016

  1. Common genetic polymorphisms within NFκB-related genes and the risk of developing invasive aspergillosis

    Frontiers in Microbiology, Vol. 7, Núm. AUG